Background Vitamin K antagonists are highly effective in preventing stroke in patients with
atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor …

Background Nesiritide is approved in the United States for early relief of dyspnea in patients
with acute heart failure. Previous meta-analyses have raised questions regarding renal …

Background— Although previous work has suggested that anemia is associated with an
increased mortality in selected patients with congestive heart failure (CHF), little is known about …

Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization,
reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is …

Since the inception of the Canadian Cardiovascular Society heart failure (HF) guidelines in
2006, much has changed in the care for patients with HF. Over the past decade, the HF …

Background: Guidelines recommend that patients with heart failure receive β-blockers in
doses used in the trials that have proven their efficacy. Although the adverse effects of β-…

Background Ferric carboxymaltose therapy reduces symptoms and improves quality of life
in patients who have heart failure with a reduced ejection fraction and iron deficiency. …

Importance The natriuretic peptides are biochemical markers of heart failure (HF) severity
and predictors of adverse outcomes. Smaller studies have evaluated adjusting HF therapy …

Background: Even with optimal pharmacotherapy, symptomatic heart failure is associated
with substantial morbidity and mortality. Purpose: To determine the efficacy and safety of …

Objectives : The purpose of this study was to examine the long-term incidence of heart
failure (HF) in elderly patients with myocardial infarction (MI). Background : In-hospital HF is …